Cargando…

Clinical and Immunological Characteristics of Patients with Biopolymers and Autoimmune Inflammatory Syndrome Induced by Adjuvants

Biopolymers consist of non-biocompatible allogeneic materials. They have been associated with autoimmune inflammatory syndrome induced by adjuvants, as described by Yehuda Shoenfeld and Nancy Agmon-Levin. Therefore, this study aimed to evaluate the clinical and immunological characteristics of patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Pachón S, Jaime Eduardo, Salazar, Marcela C., Pores, Adriana M., Rizo, Victor Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517314/
https://www.ncbi.nlm.nih.gov/pubmed/34667709
http://dx.doi.org/10.1097/GOX.0000000000003796
_version_ 1784583988939063296
author Pachón S, Jaime Eduardo
Salazar, Marcela C.
Pores, Adriana M.
Rizo, Victor Z.
author_facet Pachón S, Jaime Eduardo
Salazar, Marcela C.
Pores, Adriana M.
Rizo, Victor Z.
author_sort Pachón S, Jaime Eduardo
collection PubMed
description Biopolymers consist of non-biocompatible allogeneic materials. They have been associated with autoimmune inflammatory syndrome induced by adjuvants, as described by Yehuda Shoenfeld and Nancy Agmon-Levin. Therefore, this study aimed to evaluate the clinical and immunological characteristics of patients with autoimmune inflammatory syndrome induced by adjuvants treated at a plastic surgery clinic in Colombia. METHODS: This cross-sectional, descriptive observational study included 190 patients with biopolymers in the buttocks with no evidence of autoimmune disease who were diagnosed with autoimmune inflammatory syndrome induced by adjuvants and underwent treatment at a private plastic surgery clinic from 2017 to 2020. The clinical and paraclinical parameters were measured preoperatively, when the diagnosis of autoimmune inflammatory syndrome induced by adjuvants and the need for material removal were established, and postoperatively after 3 months. RESULTS: The most frequent symptoms were myalgia (92%), arthralgia (77.9%), asthenia (77.9%), adynamia (77.9%), and neurological symptoms (55.8%). Preoperatively, patients were positive for antinuclear antibody, lactate dehydrogenase, complement proteins C3 and C4, and lupus anticoagulant. However, after removal of the biopolymer, there was a decrease in positivity or conversion to a negative status of paraclinical tests. Moreover, there was an association between LDH positivity and disease severity (odds ratio: 4.1, 95% confidence interval: 1.94–8.92). CONCLUSIONS: The removal of biopolymers using an open surgical technique in symptomatic or asymptomatic patients is crucial for functional and reconstructive purposes and to improve the quality of life. Therefore, this condition should be known as “human adjuvant disease caused by biopolymers.” Further, this condition mimics autoimmune diseases, with clinical and paraclinical manifestations that improve biopolymer removal.
format Online
Article
Text
id pubmed-8517314
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-85173142021-10-18 Clinical and Immunological Characteristics of Patients with Biopolymers and Autoimmune Inflammatory Syndrome Induced by Adjuvants Pachón S, Jaime Eduardo Salazar, Marcela C. Pores, Adriana M. Rizo, Victor Z. Plast Reconstr Surg Glob Open Research Biopolymers consist of non-biocompatible allogeneic materials. They have been associated with autoimmune inflammatory syndrome induced by adjuvants, as described by Yehuda Shoenfeld and Nancy Agmon-Levin. Therefore, this study aimed to evaluate the clinical and immunological characteristics of patients with autoimmune inflammatory syndrome induced by adjuvants treated at a plastic surgery clinic in Colombia. METHODS: This cross-sectional, descriptive observational study included 190 patients with biopolymers in the buttocks with no evidence of autoimmune disease who were diagnosed with autoimmune inflammatory syndrome induced by adjuvants and underwent treatment at a private plastic surgery clinic from 2017 to 2020. The clinical and paraclinical parameters were measured preoperatively, when the diagnosis of autoimmune inflammatory syndrome induced by adjuvants and the need for material removal were established, and postoperatively after 3 months. RESULTS: The most frequent symptoms were myalgia (92%), arthralgia (77.9%), asthenia (77.9%), adynamia (77.9%), and neurological symptoms (55.8%). Preoperatively, patients were positive for antinuclear antibody, lactate dehydrogenase, complement proteins C3 and C4, and lupus anticoagulant. However, after removal of the biopolymer, there was a decrease in positivity or conversion to a negative status of paraclinical tests. Moreover, there was an association between LDH positivity and disease severity (odds ratio: 4.1, 95% confidence interval: 1.94–8.92). CONCLUSIONS: The removal of biopolymers using an open surgical technique in symptomatic or asymptomatic patients is crucial for functional and reconstructive purposes and to improve the quality of life. Therefore, this condition should be known as “human adjuvant disease caused by biopolymers.” Further, this condition mimics autoimmune diseases, with clinical and paraclinical manifestations that improve biopolymer removal. Lippincott Williams & Wilkins 2021-09-24 /pmc/articles/PMC8517314/ /pubmed/34667709 http://dx.doi.org/10.1097/GOX.0000000000003796 Text en Copyright © 2021 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Research
Pachón S, Jaime Eduardo
Salazar, Marcela C.
Pores, Adriana M.
Rizo, Victor Z.
Clinical and Immunological Characteristics of Patients with Biopolymers and Autoimmune Inflammatory Syndrome Induced by Adjuvants
title Clinical and Immunological Characteristics of Patients with Biopolymers and Autoimmune Inflammatory Syndrome Induced by Adjuvants
title_full Clinical and Immunological Characteristics of Patients with Biopolymers and Autoimmune Inflammatory Syndrome Induced by Adjuvants
title_fullStr Clinical and Immunological Characteristics of Patients with Biopolymers and Autoimmune Inflammatory Syndrome Induced by Adjuvants
title_full_unstemmed Clinical and Immunological Characteristics of Patients with Biopolymers and Autoimmune Inflammatory Syndrome Induced by Adjuvants
title_short Clinical and Immunological Characteristics of Patients with Biopolymers and Autoimmune Inflammatory Syndrome Induced by Adjuvants
title_sort clinical and immunological characteristics of patients with biopolymers and autoimmune inflammatory syndrome induced by adjuvants
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517314/
https://www.ncbi.nlm.nih.gov/pubmed/34667709
http://dx.doi.org/10.1097/GOX.0000000000003796
work_keys_str_mv AT pachonsjaimeeduardo clinicalandimmunologicalcharacteristicsofpatientswithbiopolymersandautoimmuneinflammatorysyndromeinducedbyadjuvants
AT salazarmarcelac clinicalandimmunologicalcharacteristicsofpatientswithbiopolymersandautoimmuneinflammatorysyndromeinducedbyadjuvants
AT poresadrianam clinicalandimmunologicalcharacteristicsofpatientswithbiopolymersandautoimmuneinflammatorysyndromeinducedbyadjuvants
AT rizovictorz clinicalandimmunologicalcharacteristicsofpatientswithbiopolymersandautoimmuneinflammatorysyndromeinducedbyadjuvants